Found: 13
Select item for more details and to access through your institution.
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 737, doi. 10.1007/s00432-022-04493-1
- By:
- Publication type:
- Article
Rare tumors: a blue ocean of investigation.
- Published in:
- Frontiers of Medicine, 2023, v. 17, n. 2, p. 220, doi. 10.1007/s11684-023-0984-z
- By:
- Publication type:
- Article
Targeting rare tumors: new focus for clinical research in China.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216415
- By:
- Publication type:
- Article
The state of the art of bispecific antibodies for treating human malignancies.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 9, p. 1, doi. 10.15252/emmm.202114291
- By:
- Publication type:
- Article
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1168, doi. 10.3390/vaccines10081168
- By:
- Publication type:
- Article
Association between germ-line HLA and immune-related adverse events.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.952099
- By:
- Publication type:
- Article
Clinical Investigations of CAR-T Cell Therapy for Solid Tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.896685
- By:
- Publication type:
- Article
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01401
- By:
- Publication type:
- Article
A Game-Theoretic Approach of Optimized Operation of AC/DC Hybrid Microgrid Clusters.
- Published in:
- Energies (19961073), 2022, v. 15, n. 15, p. 5537, doi. 10.3390/en15155537
- By:
- Publication type:
- Article
The current status and future of ADC therapy for small cell Lung Cancer: a promising approach.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04471-2
- By:
- Publication type:
- Article
Seven-year exclusivity and beyond for drugs of rare diseases in China.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1223056
- By:
- Publication type:
- Article
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01227-1
- By:
- Publication type:
- Article